Adawi Kamal — SEC insider filings
SEC reporting owner CIK 1788393. 12 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2021-02-25 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 35,592 shares, $75,167 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 9,297 shares @ $1.91 ($17,747) in EXAGEN INC., filed 2024-03-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXAGEN INC. (XGN) | CFO and Corporate Secretary | 9 | — | 5 legs · 29,010 sh · $61,642 | 6 |
| FATE THERAPEUTICS INC (FATE) | Chief Financial Officer | 3 | — | 1 leg · 6,582 sh · $13,525 | 4 |
Insider filings — Adawi Kamal
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | FATE THERAPEUTICS INC (FATE) | Sale (S): 6,582 @ $2.05 | EDGAR |
| 2026-01-16 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | EXAGEN INC. (XGN) | Sale (S): 9,297 @ $1.91 · Sale (S): 3,487 @ $1.91 | EDGAR |
| 2024-02-22 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2024-02-08 | 4 | EXAGEN INC. (XGN) | Sale (S): 6,738 @ $1.95 | EDGAR |
| 2023-03-03 | 4 | EXAGEN INC. (XGN) | Sale (S): 3,667 @ $2.30 | EDGAR |
| 2023-03-01 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2023-02-10 | 4 | EXAGEN INC. (XGN) | Sale (S): 5,821 @ $2.69 | EDGAR |
| 2022-03-02 | 4 | EXAGEN INC. (XGN) | Tax withholding (F): 3,241 @ $7.12 | EDGAR |
| 2022-02-08 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 63,500 @ $0 | EDGAR |
| 2021-02-25 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 37,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1788393 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs